Kimberly Driscoll, Ph.D.

Kimberly A. Driscoll, PhD, Associate Professor, PHHP Clinical and Health Psychology

Associate Professor

Email: k.driscoll@phhp.ufl.edu

CV – Kimberly Driscoll, Ph.D.

Biography

Kimberly Driscoll, Ph.D., is an Associate Professor in the Department of Clinical and Health Psychology at the University of Florida. She also serves as the Director of Behavioral Research in the UF Diabetes Institute. Dr. Driscoll obtained her doctorate in Clinical Psychology from Florida State University in 2005. She completed her clinical internship at Children’s Minnesota and a T32 postdoctoral fellowship in Child Behavior and Nutrition funded by NIDDK at Cincinnati Children’s Hospital Medical Center. Prior to joining UF, Dr. Driscoll was a faculty member in the Florida State University College of Medicine (2007-2015) and she served as the Associate Director of the Psychology Clinic. In 2015, Dr. Driscoll transitioned to the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus where she served as the first clinical psychologist and behavioral health researcher.

Research Focus

Dr. Driscoll’s clinical research addresses adherence to medical treatment regimens, with a focus on using technology and diabetes device downloads to assess and optimize adherence and health outcomes in type 1 diabetes. She was awarded an NIDDK K23 Career Development Award focused on improving adolescents’ type 1 diabetes self-management behaviors via tailored feedback using insulin pump downloads and problem-solving interventions. She then extended her research program through an NIDDK R03 by providing intervention to reduce clinically elevated levels of fear of hypoglycemia, which was assessed as part of a patient-reported outcomes initiative in clinic in mothers of adolescents with type 1 diabetes. Dr. Driscoll was awarded an NIDDK DP3 implementing integrated medical and psychological care to improve type 1 diabetes self-management behaviors and health outcomes via combined in-person and telemedicine visits. Her overarching research goals are to develop and implement behavioral interventions to improve adherence during routine type 1 diabetes clinical care.

Professional Memberships

  • American Diabetes Association
  • American Psychological Association Division of Pediatric Psychology
  • Behavioral Research in Diabetes Group Exchange
  • International Society of Pediatric and Adolescent Diabetes

Representative Publications

  1. Driscoll, K.A., Wang, Y., Johnson, S.B., Wright, N. & Deeb, L.C. (in press). Blood glucose monitoring before and after type 1 diabetes clinic visits. Journal of Pediatric Psychology.
  2. Corbin, K.D., Driscoll, K.A., Pratley, R.E., Smith, S.R., Maahs, D.M., Mayer-Davis, E.J. on behalf of Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON). (in press). Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact and Mechanisms. Endocrine Reviews.
  3. Forlenza, G.P., Messer, L.H., Berget, C., Wadwa, R.P., Driscoll, K.A. (in press). Biopsychosocial factors associated with satisfaction and sustained use of artificial pancreas technology and its components: A call to the technology field. Current Diabetes Reports.
  4. O’Donnell, H.K., Berget, C., Wooldridge, J., Driscoll, K.A. (in press). Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study. Pediatric Diabetes.
  5. Driscoll, K.A., Corbin, K.D., Maahs, D.M., Pratley, R., Bishop, F.K., Kahkoska, A., Hood, K.K., Mayer-Davis, E. (2017). Biopsychosocial aspects of weight management in type 1 diabetes: A review and next steps. Current Diabetes Reports, 17, 28.
  6. Driscoll, K.A., Wang, Y., Johnson, S.B., Gill, E., Wright, N., & Deeb, L.C. (2017). White coat adherence occurs in adolescents with type 1 diabetes receiving intervention to improve insulin pump adherence behaviors. Journal of Diabetes Science and Technology11, 455-460.
  7. Driscoll, K.A., Wang, Y., Johnson, S.B., Lynch, R., Stephens, H., Willbur, K., Gill, E., Wright, N., & Deeb, L.C. (2016). White coat adherence in pediatric patients with type 1 diabetes who use insulin pumps. Journal of Diabetes Science and Technology, 10, 724-9.
  8. Driscoll, K.A., Volkening, L., Haro, H., Ocean, G., Wang, Y., Crismond Jackson, C., Clogherty, M., Hale, D.E., Klingensmith, G.J., Laffel, L., Deeb, L.C., & Siminerio, L.M. (2015). Are children with type 1 diabetes safe at school? Examining parent perceptions. Pediatric Diabetes16, 613-620.
  9. Driscoll, K.A., Johnson S.B., Tang Y., Yang F., Deeb, L.C., & Silverstein J. (2011). Does blood glucose monitoring increase prior to clinic visits in children with type 1 diabetes? Diabetes Care, 34, 2170-2173. PMCID: 3177735.
  10. Driscoll, K.A., Johnson, S.B., Schatz, D.A., & Haller, M.J. (2011). Use of a precious resource: Parental decision making and experiences associated with a trial to interdict type 1 diabetes using autologous umbilical cord blood. Contemporary Clinical Trials, 32, 524-529. PMCID: 3129744.